Ladenburg Thalmann initiated coverage on Immutep with a new price target
$IMMP
Biotechnology: Pharmaceutical Preparations
Health Care
Ladenburg Thalmann initiated coverage of Immutep with a rating of Buy and set a new price target of $8.30
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/17/2024 | $10.00 | Overweight | CapitalOne |
| 8/3/2023 | $7.00 | Outperform | Robert W. Baird |
| 8/3/2021 | $8.30 | Buy | Ladenburg Thalmann |
| 7/16/2021 | $8.00 | Buy | Maxim Group |